ArticleHepatology international2024
Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated.
Sai Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.